Design, Synthesis, and Preliminary Immunological Studies of MUC1-Based Antitumor Vaccines Adjuvanted with R- and S-FSL-1-Reference-Cited by-同舟云学术

Design, Synthesis, and Preliminary Immunological Studies of MUC1-Based Antitumor Vaccines Adjuvanted with R- and S-FSL-1

Published:2020-06-22 Issue:7 Volume:11 Page:1371-1376
ISSN:1948-5875
Container-title:ACS Medicinal Chemistry Letters
language:en
Short-container-title:ACS Med. Chem. Lett.

Author:

Liu Yonghui¹,Yan Bocheng¹,Wang Zhaoyu¹,Zhu Haomiao¹,Yin Xiaona¹,Wang Kun¹,Wang Menglei¹,Zhao Wei¹^ORCID

Affiliation:

1. State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy, Key Laboratory of Molecular Drug Research and KLMDASR of Tianjin, Nankai University, No. 38 Tongyan Road, Haihe Education Park, Tianjin 300353, P. R. China

Funder

Natural Science Foundation of Tianjin City

Ministry of Education of the People's Republic of China

Ministry of Science and Technology of the People's Republic of China

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Drug Discovery,Biochemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acsmedchemlett.9b00579

Reference33 articles.

1. Immunotherapy: past, present and future

2. Developments in virus-like particle-based vaccines for infectious diseases and cancer

3. Development of Globo-H Cancer Vaccine

4. The development of synthetic antitumour vaccines from mucin glycopeptide antigens

5. Therapeutic vaccines for cancer: an overview of clinical trials

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Trichostatin A-modified vaccine provides superior protection against ovarian cancer formation and development;Brazilian Journal of Medical and Biological Research;2024

2. Development of a novel modified vaccine (TheraVacM) for curative treatment of mouse solid tumors;Cytokine;2023-09

3. Pushing the envelope: Immune mechanism and application landscape of macrophage-activating lipopeptide-2;Frontiers in Immunology;2023-01-24

4. An efficient and safe MUC1-dendritic cell-derived exosome conjugate vaccine elicits potent cellular and humoral immunity and tumor inhibition in vivo;Acta Biomaterialia;2022-01